Status:
COMPLETED
The Impact of Post-operative Voiding Trial on Length of Stay Following Laparoscopic Hysterectomy: A Prospective, Randomized Control Trial
Lead Sponsor:
Brigham and Women's Hospital
Conditions:
Minimally Invasive Surgical Procedure
Hysterectomy
Eligibility:
FEMALE
18-99 years
Phase:
NA
Brief Summary
The aim of this study is to investigate the impact of an active voiding trial compared to a passive voiding trial on time to discharge following a planned same day discharge laparoscopic hysterectomy....
Detailed Description
Following laparoscopic surgery with hysterectomy, there is no standard method for assuring urinary function prior to discharge. Total laparoscopic hysterectomy (TLH) has been demonstrated to be safe w...
Eligibility Criteria
Inclusion
- Patients scheduled to undergo a total laparoscopic hysterectomy by a gynecologic oncology surgeon for either benign or malignant disease
- planned same day discharge surgery
Exclusion
- history of significant urinary dysfunction (such as home catheterization) or neurologic dysfunction precluding spontaneous voiding
- bilateral radical pelvic dissection (defined as bilateral ureterolysis or removal of bilateral parametria)
- surgical cases converted to laparotomy or open surgery
- Surgical or medical contra-indications (based on the surgeons or anesthesiologists' recommendations) to same day discharge requiring inpatient admission
Key Trial Info
Start Date :
January 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 4 2017
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04487600
Start Date
January 1 2017
End Date
August 4 2017
Last Update
November 24 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.